Evaluation of TREM1 gene expression in circulating polymorphonuclear leukocytes and its inverse correlation with the severity of pathophysiological conditions in patients with acute bacterial infections

Japanese Journal of Infectious Diseases

Volumn 65, Issue 5, 2012, Pages 376-382

  Ubagai, Tsuneyuki ^a   Tansho, Shigeru ^a   Ieki, Ryuji ^b   Ono, Yasuo ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO METROPOLITAN BOKUTOH HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD14 ANTIGEN; INTERLEUKIN 6; MESSENGER RNA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; CD14 GENE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; INTERLEUKIN 6 GENE; INTERLEUKIN 8 RECEPTOR A GENE; MAC1 GENE; MALE; NEUTROPHIL; NUCLEOTIDE SEQUENCE; PNEUMONIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS; SEPTIC SHOCK; TOLL LIKE RECEPTOR 2 GENE; TOLL LIKE RECEPTOR 4 GENE; TREM1 GENE; TUMOR NECROSIS FACTOR ALPHA GENE; UPREGULATION;

ACUTE DISEASE; AGED; BACTEREMIA; CASE-CONTROL STUDIES; CYTOKINES; DOWN-REGULATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HOST-PATHOGEN INTERACTIONS; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEUTROPHILS; PNEUMONIA, BACTERIAL; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, IMMUNOLOGIC; RNA, MESSENGER;

EID: 84869847079     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: 10.7883/yoken.65.376     Document Type: Article

References (54)

1. World Health Organization (2005): Burden of Disease Project. World Health Organization, Gneneva. Online at . Accessed 10 November 2005.
2. Angus, D.C. and Wax, R.S. (2001): Epidemiology of sepsis: an update. Crit. Care Med., 29 (Suppl 7), 109-116.
3. Zaidi, A.K., Thaver, D., Ali, S.A., et al. (2009): Pathogens associated with sepsis in newborns and young infants in developing countries. Pediatr. Infect. Dis. J., 28 (Suppl 1), 10-18.
4. Fauci, A.S. (2005): The global challenge of infectious diseases: the evolving role of the National Institutes of Health in basic and clinical research. Nat. Immunol., 6, 743-747.
5. Segal, A.W. (2005): How neutrophils kill microbes. Annu. Rev. Immunol., 23, 197-223.
6. Medzhitov, R. and Janeway, C.A., Jr. (1997): Innate immunity: the virtues of a nonclonal system of recognition. Cell, 91, 295-298.
7. Medzhitov, R. and Janeway, C.A., Jr. (2000): Innate immune recognition: mechanisms and pathways. Immunol. Rev., 173, 89-97.
8. Dale, D.C., Boxer, L. and Liles, W.C. (2008): The phagocytes: neutrophils and monocytes. Blood, 112, 935-945.
9. Akira, S. and Takeda, K. (2004): Toll-like receptor signaling. Nat. Rev. Immunol., 4, 499-511.
10. Akira, S., Uematsu, S. and Takeuchi, O. (2006): Pathogen recognition and innate immunity. Cell, 124, 783-801.
11. Jeyaseelan, S., Chu, H.W., Young, S.K., et al. (2005): Distinct roles of pattern recognition receptors CD14 and Toll-like receptor 4 in acute lung injury. Infect. Immun., 73, 1754-1763.
12. Swain, S.D., Rohn, T.T. and Quinn, M.T. (2002): Neutrophil priming in host defense: role of oxidants as priming agents. Antioxid. Redox. Signal., 4, 69-83.
13. Reumaux, D., Vossebeld, P.J.M., Roos, D., et al. (1995): Effect of tumor necrosis factor-induced integrin activation on Fcg receptor II-mediated signal transduction: relevance for activation of neutrophils by anti-proteinase 3 or anti-myeloperoxidase antibodies. Blood, 86, 3189-3195.
14. Csernok, E., Ernst, M., Schmitt, W., et al. (1994): Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin. Exp. Immunol., 95, 244-250.
15. Porges, A.J., Redecha, P.B., Kimberly, W.T., et al. (1994): Antineutrophil cytoplasmic antibodies engage and activate human neutrophils via FcgRIIa. J. Immunol., 153, 1271-1280.
16. Harper, L., Radford, D., Plant, T., et al. (2001): IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytoplasmic antibody-positive patients. Arthritis Rheum., 44, 921-930.
17. Liu, S.F. and Malik, A.B. (2006): NF-kB activation as a pathological mechanism of septic shock and inflammation. Am. J. Physiol. Lung Cell Physiol., 290, L622-645.
18. Lee, J., Horuk, R., Rice, G.C., et al. (1992): Characterization of two hige affinity human interleukin-8 receptors. J. Biol. Chem., 267, 16283-16287.
19. Holmes, W.E., Lee, J., Kuang, W.J., et al. (1991): Structure and functional expression of a human interleukin-8 receptor. Science, 253, 1278-1280.
20. Stillie, R., Farooq, S.M., Gordon, J., et al. (2009): The functional significance behind expressing two IL-8 receptor types on PMN. J. Leukoc. Biol., 86, 529-543.
21. Perera, P.Y., Mayadas, T.N., Takeuchi, O., et al. (2001): CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression. J. Immunol., 166, 574-581.
22. Fessler, M.B., Arndt, P.G., Frasch, S.C., et al. (2004): Lipid rafts regulate lipopolysaccharide-induced activation of Cdc42 and inflammatory functions of the human neutrophils. J. Biol. Chem., 279, 39989-39998.
23. Colonna, M. (2003): TREMs in the immune system and beyond. Nat. Rev. Immunol., 3, 445-453.
24. Bouchon, A., Dietrich, J. and Colonna, M. (2000): Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J. Immunol., 164, 4991-4995.
25. Gibot, S., Cravoisy, A., Bruno, L., et al. (2004): Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N. Engl. J. Med., 350, 451-458.
26. Klesney-Tait, J., Turnbull, I.R., and Colonna, M. (2006): The TREM receptor family and signal integration. Nat. Immunol., 7, 1266-1273.
27. Kohno, S. (ed.) (2008): The JRS Guidelines for the Management of Community-Acquired Pneumonia in Adults. The Japanese Respiratory Society Publishing, Tokyo, Japan.
28. Bone, R.C., Balk, R.A., Cerra, F.B., et al. (1992): Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest, 101, 1644-1655.
29. Ubagai, T., Tansho, S., Ito, T., et al. (2008): Influences of aflatoxin B1 on reactive oxygen species generation and chemotaxis of human polymorphonuclear leukocytes. Toxicol. In Vitro, 22, 1115-1120.
30. Ubagai, T., Koshibu, Y., Koshio, O., et al. (2009): Downregulation of immunomodulator gene expression in LPS-stimulated human polymorphonuclear leukocytes by the proton pump inhibitor lansoprazole. J. Infect. Chemother., 15, 374-379.
31. Nathan, C. (2006): Neutrophils and immunity: challenges and opportunities. Nat. Rev. Immunol., 6, 173-182.
32. Kawai, T. and Akira, S. (2009): The roles of TLRs, RLRs, and NLRs in pathogen recognition. Int. Immumol., 21, 317-337.
33. Balamayooran, G., Batra, S., Fessler, M.B., et al. (2010): Mechanisms of neutrophil accumulation in the lungs against bac teria. Am. J. Respir. Cell Mol. Biol., 43, 5-16.
34. Miyake, K. (2007): Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors. Semin. Immunol., 19, 3-10.
35. Alves-Filho, J.C., de Freitas, A., Russo, M., et al. (2006): Tolllike receptor 4 signaling leads to neutrophil migration impairment in polymicrobial sepsis. Crit. Care Med., 34, 461-470.
36. Lloyd, A.R., Biragyn, A., Johnston, J.A., et al. (1995): Granulocyte-colony stimulating factor and lipopolysachaareide regulate the expression of interleukin 8 receptors on polymorphonuclear leukocytes. J. Biol. Chem., 270, 28188-28192.
37. Kobayashi, S.D., Braughton, K.R., Whitney, A.R., et al. (2003): Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils. Proc. Natl. Acad. Sci. USA, 100, 10948-10953.
38. Khandaker, M.H., Mitchell, G., Xu, L., et al. (1999): Metalloproteinases are involved in lipopolysachaaride-and tumor necrosis factor-a-mediated regulation of CXCR1 and CXCR2 chemokine receptor expression. Blood, 93, 2173-2185.
39. Khandaker, M.H., Xu, L., Rahimpour, R., et al. (1998): CXCR1 and CXCR2 are rapidly down-regulated by bacterial endotoxin through a unique agonist-independent, tyrosine kinase-dependent mechanism. J. Immunol., 161, 1930-1938.
40. Alves-Filho, J.C., de Freitas, A., Souto, F.O., et al. (2009): Regulation of chemokine receptor by Toll-like receptor 2 is critical to neutrophil migration and resistance to polymicrobial sepsis. Proc. Natl. Acad. Sci. USA, 106, 4018-4023.
41. Reumaux, D., Mull, F.P.J., Hordijk, P.L., et al. (2002): Effect of TNF-a on Fcg receptor IIa (FcgRIIa) and b2-integrin distribution on neutrophil surface analyzed by confocal laser scanning microscopy. Clevel. Clin. J. Med., 69 (Suppl 2), SII-163.
42. Baeuerle, P.A. and Baichwal, V.R. (1997): NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv. Immunol., 65, 111-137.
43. Brown, M.A. and Jones, W.K. (2004): NF-kappa B action in sepsis: the innate immune system and the heart. Front. Biosci., 9, 1201-1217.
44. Pahl, H.L. (1999): Activators and target genes of Rel/NF-kappa B transcription factors. Oncogene, 18, 6853-6866.
45. Liu, S.F., Ye, X.B. and Malik, A.B. (1997): In vivo inhibition of NF-kB activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock. J. Immunol., 159, 3976-3983.
46. Liu, S.F., Ye, X.B. and Malik, A.B. (1999): Inhibition of NF-kB activation by pyrrolidine dithiocarbamate prevents in vivo expression proinflammatory genes. Circulation, 100, 1330-1337.
47. Liu, S.F., Ye, X.B. and Malik, A.B. (1999): Pyrrolidine dithiocarbamate prevents I-kB degradation and reduces microvascular injury induced by lipopolysaccharide in multiple organs. Mol. Pharmacol., 55, 658-667.
48. Sabroe, I., Williams, T.J., Hebert, C.A., et al. (1997): Chemoattractant cross-desensitization of the human neutrophil IL-8 receptor involves receptor internalization and differential receptor subtype regulation. J. Immunol., 158, 1361-1369.
49. Richardson, R.M., Pridgen, B.C., Haribabu, B., et al. (1998): Differential cross-regulation of the human chemokine receptors CXCR1 and CXCR2. Evidence for time-dependent signal generation. J. Biol. Chem., 273, 23830-23836.
50. Ali, H., Richardson, R.M., Haribabu, B., et al. (1999): Chemoattractant receptor cross-desensitization. J. Biol. Chem., 274, 6027-6030.
51. Mathy, K.A. and Koepke, J.A. (1974): The clinical usefulness of segmented vs stab neutrophil criteria for differential leukocyte counts. Am. J. Clin. Pathol., 61, 947-958.
52. Dresch, C., Flandrin, G. and Breton-Gorius, J. (1980): Phagocytosis of neutrophil polymorphonuclears by macrophages in human bone marrow: importance in granulopoesis. J. Clin. Pathol., 33, 1110-1113.
53. Gibot, S. and Cravoisy, A. (2004): Soluble form of the triggering receptor expressed on myeloid cells-1 as a marker of microbial infection. Clin. Med. Res., 2, 181-187.
54. Gibot, S., Massin, F., Marcou, M., et al. (2007): TREM-1 promotes survival during septic shock in mice. Eur. J. Immunol., 37, 456-466.